John E. Villafranco

Articles

Are supplement companies responsible for the health claims its customers make in social media?

Analysis of a proposed advertising ban in the context of Joe Camel

Tips for avoiding legal risk by disclosing connections between advertisers and endorsers.

Labeling caffeine content is a job for all industry members.

Why your NAD challenges will build a stronger marketplace for dietary supplements. 

The FTC’s recent opinion in the POM Wonderful pomegranate case reveals more about the agency’s view on health-benefit claims.

Dietary supplement companies have seen an increasing number of piggyback class action lawsuits.

What to consider if the clinical trial substantiating your U.S. advertising claim is conducted in a foreign country.

How growing FDA and FTC collaboration changes the regulatory landscape for food and dietary supplement marketers.